Page 128 - Vitamin D and Cancer
P. 128

Chapter 6
            Vitamin D: Cardiovascular Function
            and Disease



            Robert Scragg







            Abstract  Opinions about the effect of vitamin D on risk of cardiovascular disease
            have changed substantially over the last half century. During the 1950s and 1970s,
            the dominant view was that vitamin D was a cause of cardiovascular disease. During
            the 1980s and 1990s, an increasing number of studies showed benefits from vitamin
            D, challenging earlier opinions that vitamin D was harmful. During the first decade
            of this century, the weight of scientific opinion has shifted 180° from that of 50 years
            ago, and the prevailing focus of research is on identifying the potential beneficial
            effects of vitamin D against cardiovascular disease. Since 2003, large epidemiological
            studies of hemodialysis patients and general population samples have shown inverse
            associations between vitamin D and cardiovascular disease. A growing body of labo-
            ratory and clinical research has identified several possible mechanisms to explain this
            association. These include adverse effects of vitamin D deficiency on immune and
            inflammatory processes, endothelial function, matrix-metalloproteinases and insulin
            resistance, which result in cardiac hypertrophy, thickened arteries, increased plaque
            formation, and rupture and thrombosis. Large randomized trials are required to deter-
            mine with certainty whether vitamin D  protects against cardiovascular disease.

            Keywords  25-hydroxyvitamin D • Cardiovascular disease • Hypertension • Vitamin D


            Abbreviations

            CI          Confidence interval
            CRP         C-reactive protein
            CV          Cardiovascular
            1,25(OH) D  1,25-Dihydroxyvitamin D
                   2
            25OHD       25-Hydroxyvitamin D
            IL          Interleukin
            MMP         Matrix-metallo-protease

            R. Scragg (*)
            School of Population Health, University of Auckland, Private Bag 92019,
            Auckland 1142, New Zealand
            e-mail: r.scragg@auckland.ac.nz


            D.L. Trump and C.S. Johnson (eds.), Vitamin D and Cancer,       115
            DOI 10.1007/978-1-4419-7188-3_6, © Springer Science+Business Media, LLC 2011
   123   124   125   126   127   128   129   130   131   132   133